Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.
Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks. · Barrons.com

In This Article:

The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash-pay options. A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients. President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as a blow against drugmakers.